A randomized controlled trial on the influence of structured advance care planning on quality of end-of-life care communication and quality of end-of-life care in patients with COPD.

Completed

• Conditions: 10006436; chronic obstructive pulmonary disease; COPD

• Registration Number: NL-OMON40110
• Lead Sponsor: Astmacentrum Hornerheide

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 11 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 900

Inclusion Criteria

Patients:
- A diagnosis of severe to very severe COPD (GOLD grade III or IV or quadrant D) according to GOLD guidelines.
- Initiation of oxygen therapy or discharged after hospital admission for an acute COPD exacerbation.
-At least one loved one, who will participate in the study.

Exclusion Criteria

- Unable to complete the study questionnaires because of cognitive impairment.
- Unable to speak or understand Dutch.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main study parameters will be:<br /><br>- Quality of communication about end-of-life care<br /><br>- Symptoms of anxiety and depression<br /><br>- Quality of end-of-life care<br /><br>- Quality of dying</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>The secondary parameters will be:<br /><br>- Patient*s preferences for end-of-life care<br /><br>- Received end-of-life care<br /><br>- Psychological distress in bereaved family members of deceased patients with<br /><br>COPD </p><br>